Avid Tradex Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 17-12-2024
- Paid Up Capital ₹ 0.10 M
as on 17-12-2024
- Company Age 5 Year, 8 Months
- Last Filing with ROC 31 Mar 2022
- Revenue 143.42%
(FY 2022)
- Profit 92.83%
(FY 2022)
- Ebitda 43.18%
(FY 2022)
- Net Worth 85.37%
(FY 2022)
- Total Assets -2.87%
(FY 2022)
About Avid Tradex
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Akshay Dalvi and Apoorv Chopde serve as directors at the Company.
- CIN/LLPIN
U51909MH2019PTC323616
- Company No.
323616
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Apr 2019
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Avid Tradex Private Limited offer?
Avid Tradex Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, HIV Drugs, TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Common Disease Medicines, Pharmaceutical Tablets, Anti Smoking Drugs, Cardiovascular Drugs & Medication, Antidiabetic Medicine, Skin Lightening Drugs.
Who are the key members and board of directors at Avid Tradex?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Akshay Dalvi  | Director | 18-Feb-2020 | Current |
| Apoorv Chopde | Director | 03-Apr-2019 | Current |
Financial Performance of Avid Tradex.
Avid Tradex Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 143.42% increase. The company also saw a substantial improvement in profitability, with a 92.83% increase in profit. The company's net worth Soared by an impressive increase of 85.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Avid Tradex?
Unlock access to Avid Tradex's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Avid Tradex?
Unlock and access historical data on people associated with Avid Tradex, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Avid Tradex, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Avid Tradex's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
